OPRX - OptimizeRx expects Q3 revenue to surge 100%

For Q3, OptimizeRx (OPRX) +1.4% PM, expects revenue to total $10M+ (+100% Y/Y) led by investments made in commercial team, acquisition strategy and platform extensions.It forecasts a positive non-GAAP net income for the quarter."Our topline growth was driven organically with a combination of enterprise deals and tactical programs, as our customers increasingly see the value in transparent access to physicians and patients via our digital health platform," CEO William Febbo commented.For 9M, revenue grew at faster pace (53%) to $26.4M."As we begin the final quarter of the year, we continue to hit on all our growth drivers, including expanded physician and patient reach, new and scaling clients, and additional solutions. This is all working together to keep us on course for a strong finish to the year. We see this momentum continuing into 2021, as our sales pipeline continues to expand as anticipated," Febbo added.Q3 is scheduled to be reported in November

For further details see:

OptimizeRx expects Q3 revenue to surge 100%